{
  "ticker": "LLY",
  "target_date": "2025-06-10",
  "actual_date": "2025-06-10",
  "collected_at": "2025-12-08T11:52:19.087111",
  "price": {
    "open": 774.25,
    "high": 805.67,
    "low": 774.16,
    "close": 804.2398681640625,
    "volume": 4744400,
    "change_1d_pct": 4.33,
    "change_7d_pct": 9.42,
    "change_30d_pct": -7.8
  },
  "technicals": {
    "rsi_14": 71.68,
    "sma_20": 741.72,
    "sma_50": 770.64,
    "macd": 0.283,
    "macd_signal": -9.347,
    "macd_histogram": 9.63,
    "bb_upper": 790.68,
    "bb_lower": 692.77,
    "price_vs_sma20_pct": 8.43,
    "price_vs_sma50_pct": 4.36,
    "volume_ratio": 1.21
  },
  "fundamentals": {
    "market_cap": 891615903744,
    "pe_ratio": 48.731014,
    "forward_pe": 43.89232,
    "price_to_book": 37.44729,
    "price_to_sales": 15.005367,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.56,
    "pct_from_52w_low": 59.45
  },
  "macro": {
    "spy": {
      "price": 599.64,
      "change_1d_pct": 0.57,
      "change_7d_pct": 1.75
    },
    "vix": {
      "level": 16.95,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.47
    },
    "dollar_index": {
      "level": 99.05
    },
    "gold": {
      "price": 3320.9
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Eli Lilly telehealth deals to prevent sale of compounded GLP-1s",
      "source": "Yahoo",
      "datetime": 1749587239,
      "summary": "Eli Lilly (LLY) revealed a new stipulation regarding its business dealings with telehealth companies Ro and LifeMD (LFMD), ensuring that compounded versions of its GLP-1 weight-loss drugs are not being sold on these sites. Yahoo Finance senior health reporter Anjalee Khemlani sheds more light on thi",
      "url": "https://finnhub.io/api/news?id=ec9513f640ef032864379a14fc4a55ac70e3547d17452cb6025dd439353fab53"
    },
    {
      "headline": "Sector Update: Health Care Stocks Rise Late Afternoon",
      "source": "Yahoo",
      "datetime": 1749585761,
      "summary": "Health care stocks advanced late Tuesday afternoon, with the NYSE Health Care Index rising 1.2% and",
      "url": "https://finnhub.io/api/news?id=b7a8a23e76b3e6643cbf3218c2bcdb6adaf02af2a32678fe423c8492ccb6a3b0"
    },
    {
      "headline": "Hims & Hers stock falls after Lilly rules out partnership",
      "source": "Yahoo",
      "datetime": 1749584123,
      "summary": "Investing.com -- Hims & Hers Health Inc (NYSE:HIMS) stock fell 3.8% Tuesday after Eli Lilly and Company (NYSE:LLY) indicated it would not partner with telehealth firms selling copycat versions of weight-loss drugs, effectively ruling out a potential deal with Hims.",
      "url": "https://finnhub.io/api/news?id=9fbd6ec5b368578a2dfdeb1e22ff639ea1e7f708b61db31c3f72d80e2e4b7f64"
    },
    {
      "headline": "Update: Market Chatter: Lilly to Only Work With Telehealth Companies That Don't Sell Copycat Zepbound",
      "source": "Yahoo",
      "datetime": 1749578935,
      "summary": "(Updates with Eli Lilly's response to a request for comment in the third paragraph.) Eli Lilly (L",
      "url": "https://finnhub.io/api/news?id=2bc712c9f9a00cafeb28870fa7d949ada3c0106092690bd26dc972f90a514339"
    },
    {
      "headline": "Drug pricing reform talks with US government lack clarity, industry executives say",
      "source": "Yahoo",
      "datetime": 1749578610,
      "summary": "(Reuters) -Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and how reduced prices will be implemented, top executives from Eli Lilly and Merck said at an industry conference on Tuesday.  President Donald Trump issued an executive order las",
      "url": "https://finnhub.io/api/news?id=4333645898d656fc9c6507d59c37af38c8adde357a5cd3728bb41ed13151f54d"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-05-27",
      "description": "xslF345X05/wk-form4_1748376794.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000156/xslF345X05/wk-form4_1748376794.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772733.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000154/xslF345X05/wk-form4_1747772733.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772668.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000152/xslF345X05/wk-form4_1747772668.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772589.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000150/xslF345X05/wk-form4_1747772589.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772518.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000148/xslF345X05/wk-form4_1747772518.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}